468 related articles for article (PubMed ID: 15570675)
21. Labeling for bronchodilators to treat asthma; cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2011 Jul; 76(143):44475-89. PubMed ID: 21796845
[TBL] [Abstract][Full Text] [Related]
22. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Aug; 65(148):46864-8. PubMed ID: 11067707
[TBL] [Abstract][Full Text] [Related]
23. Antidiarrheal drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Apr; 68(74):18869-82. PubMed ID: 12701600
[TBL] [Abstract][Full Text] [Related]
24. Astringent drug products that produce aluminum acetate; skin protectant drug products for over-the-counter human use; technical amendment. Final rule; technical amendment.
Food and Drug Administration, HHS
Fed Regist; 2009 Mar; 74(43):9759-65. PubMed ID: 19418638
[TBL] [Abstract][Full Text] [Related]
25. Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule.
Fed Regist; 1999 Aug; 64(158):44653-8. PubMed ID: 10558603
[TBL] [Abstract][Full Text] [Related]
26. Labeling of diphenhydramine-containing drug products for over-the-counter human use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Dec; 67(235):72555-9. PubMed ID: 12474879
[TBL] [Abstract][Full Text] [Related]
27. Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Aug; 65(168):52302-5. PubMed ID: 11067736
[TBL] [Abstract][Full Text] [Related]
28. Over-the-counter vaginal contraceptive and spermicide drug products containing nonoxynol 9; required labeling. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Dec; 72(243):71769-85. PubMed ID: 18159651
[TBL] [Abstract][Full Text] [Related]
29. Skin protectant drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(107):33362-81. PubMed ID: 12785379
[TBL] [Abstract][Full Text] [Related]
30. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; partial final rule for combination drug products containing a bronchodilator. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2001 Sep; 66(188):49276-8. PubMed ID: 11758596
[TBL] [Abstract][Full Text] [Related]
31. Classification of benzoyl peroxide as safe and effective and revision of labeling to drug facts format; topical acne drug products for over-the-counter human use; final rule.
Food and Drug Administration, HHS
Fed Regist; 2010 Mar; 75(42):9767-77. PubMed ID: 20383916
[TBL] [Abstract][Full Text] [Related]
32. Anorectal drug products for over-the-counter human use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Aug; 68(165):51167-70. PubMed ID: 12952012
[TBL] [Abstract][Full Text] [Related]
33. Drug labeling; orally ingested over-the-counter drug products containing calcium, magnesium, and potassium. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Mar; 69(57):13725-35. PubMed ID: 15040351
[TBL] [Abstract][Full Text] [Related]
34. Organ-specific warnings; internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Apr; 74(81):19385-409. PubMed ID: 19507324
[TBL] [Abstract][Full Text] [Related]
35. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final monograph for combination drug products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Dec; 67(246):78158-72. PubMed ID: 12508820
[TBL] [Abstract][Full Text] [Related]
36. Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use; delay of compliance dates. Final rule; delay of compliance dates; request for comments.
Food and Drug Administration, HHS
Fed Regist; 2012 May; 77(92):27591-3. PubMed ID: 22606729
[TBL] [Abstract][Full Text] [Related]
37. Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final rule for professional labeling of aspirin, buffered aspirin, and aspirin in combination with antacid drug products; technical amendments. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule; technical amendments.
Fed Regist; 1999 Sep; 64(177):49652-5. PubMed ID: 10915461
[TBL] [Abstract][Full Text] [Related]
38. Dandruff, seborrheic dermatitis, and psoriasis drug products containing coal tar and menthol for over-the-counter human use; amendment to the monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Mar; 72(43):9849-52. PubMed ID: 17447341
[TBL] [Abstract][Full Text] [Related]
39. Status of certain additional over-the-counter drug category II and III active ingredients--FDA. Final rule.
Fed Regist; 1998 Apr; 63(77):19799-802. PubMed ID: 10179316
[TBL] [Abstract][Full Text] [Related]
40. Additional criteria and procedures for classifying over-the-counter drugs as generally recognized as safe and effective and not misbranded. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Jan; 67(15):3060-76. PubMed ID: 11820251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
